L02AE02 leuprorelin
ATC group of level 5 – chemical substance · in plain English: hormone treatment of cancer
This site has the patient leaflet or the SPC of 17 medicines in this group.
- 16 prescription only (POM)
- 1 no longer supplied or not available
Active substance: Leuprorelin – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
- L02A Hormones and related agents 44 medicines
- L02AE Gonadotropin releasing hormone analogues, endocrine therapy drugs 29 medicines
- L02AE02 leuprorelin 17 medicines
- L02AE Gonadotropin releasing hormone analogues, endocrine therapy drugs 29 medicines
- L02A Hormones and related agents 44 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
Medicines
Other groups of the same level
- L02AE01 buserelin 3 medicines
- L02AE03 goserelin 4 medicines
- L02AE04 triptorelin 5 medicines
Other names of the ATC group
- Czech: L02AE02 Leuprorelin
- French: L02AE02 leuproréline
- German: L02AE02 Leuprorelin
- Spanish: L02AE02 LEUPRORELINA
- German: L02AE02 Leuprorelin
- Italian: L02AE02 LEUPRORELINA
- Polish: L02AE02 LEUPRORELINA
- Turkish: L02AE02 leuprorelin
- Portuguese (Brazil): L02AE02 Leuprorelina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L02AE02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
